AI translation creates audit trail risks for regulated content. Learn the five gaps to close before a translated file is audited.

Practical articles on translation quality, AI in regulated content, terminology and market entry, written by the linguists and project leads who do the work.

AI translation creates audit trail risks for regulated content. Learn the five gaps to close before a translated file is audited.
Maybe you’re a medical publisher with patient information sheets that need updating after every regulatory change. Maybe you’re a digital therapeutics platform, and a single algorithm update cascades into 26 language versions.
If you’re coordinating clinical trial transparency across multiple EU markets, you’ve probably encountered this. The Annex V structure is identical. The clinical data hasn’t changed.
You’ve checked the clinical data, and the science is solid. The English source is impeccable, and your launch timeline is set. And yet, something feels off with the French-language versions of your medical content.
Regulatory reviewers expect translations to be precise and consistent. Patients need information that’s clear, accessible, and culturally appropriate. And project timelines rarely allow for second chances.